Subject: Fines totalling €373,943.38 imposed on undertakings active in the supply of medical products following decision adopted under the Settlement Procedure (SP).
Decision on the ex officio investigation conducted by the HCC’s Directorate-General for Competition (DGC) to determine whether the conditions for application of the provisions of Article 1 of L. 3959/2011 on the “Protection of Free Competition” (Greek Competition Act), as in force, and Article 101 of the Treaty on the Functioning of the European Union (TFEU) are met, in the context of the public tender launched by the National Central Health Procurement Authority (EKAPY) under the contract notice “Call for tenders for the urgent procurement of medical products for SARS-CoV-2 rapid antigen tests (rapid tests), with the most economically advantageous tender, solely on the basis of the price for the provision of the tendered products, being the award criterion and a total estimated value of 28,549,800.00 euros”(ESIDIS Registry No 145316), published on the 30rd of November 2021, regarding potential anticompetitive practices in the context of a horizontal or vertical agreement.
